Rapeseed oil and ginseng saponins work synergistically to enhance Th1 and Th2 immune responses induced by the foot-and-mouth disease vaccine

Clinical and Vaccine Immunology

Volumn 21, Issue 8, 2014, Pages 113-1119

  Zhang, Cenrong ^a   Wang, Yuemin ^a   Wang, Meng ^a   Su, Xiaoyan ^a   Lu, Yisong ^a   Su, Fei ^a   Hu, Songhua ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CONCANAVALIN A; FOOT AND MOUTH DISEASE VACCINE; FOOT AND MOUTH DISEASE VIRUS ANTIGEN; GAMMA INTERFERON; GINSENG ROOT SAPONIN; GINSENG SAPONIN; GINSENG STEM LEAF SAPONIN; IMMUNOGLOBULIN G; INTERLEUKIN 5; LIPOPOLYSACCHARIDE; RAPESEED OIL; UNCLASSIFIED DRUG; VIRUS ANTIGEN; IL5 PROTEIN, HUMAN; IMMUNOLOGICAL ADJUVANT; SAPONIN; VEGETABLE OIL; VIRUS ANTIBODY; VIRUS VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY SPECIFICITY; ARTICLE; BONE MARROW CELL; CONTROLLED STUDY; DRUG POTENTIATION; FEMALE; FOOT AND MOUTH DISEASE; FOOT AND MOUTH DISEASE VIRUS; IMMUNE RESPONSE; IMMUNOGLOBULIN BLOOD LEVEL; INFECTION PREVENTION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SECRETORY CELL; SPLEEN CELL; TH1 CELL; TH2 CELL; ANIMAL; BLOOD; CELL PROLIFERATION; CYTOLOGY; FOOT-AND-MOUTH DISEASE; IMMUNOLOGY; INSTITUTE FOR CANCER RESEARCH MOUSE; LYMPHOCYTE ACTIVATION; METABOLISM; PANAX; SPLEEN;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; CELL PROLIFERATION; CONCANAVALIN A; FEMALE; FOOT-AND-MOUTH DISEASE; FOOT-AND-MOUTH DISEASE VIRUS; IMMUNOGLOBULIN G; INTERFERON-GAMMA; INTERLEUKIN-5; LIPOPOLYSACCHARIDES; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED ICR; PANAX; PLANT OILS; SAPONINS; SPLEEN; TH1 CELLS; TH2 CELLS; VIRAL VACCINES;

EID: 84906682913     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00127-14     Document Type: Article

References (36)

1. Cao Y, Lu Z, Li D, Fan P, Sun P, Bao H, Fu Y, Li P, Bai X, Chen Y, Xie B, Liu Z. 2014. Evaluation of cross-protection against three topotypes of serotype O foot-and-mouth disease virus in pigs vaccinated with multi-epitope protein vaccine incorporated with poly(I:C). Vet. Microbiol. 168:294-301. http://dx.doi.org/10.1016/j.vetmic.2013.11.023.
2. Li D, Zhou C, She D, Li P, Sun P, Bai X, Chen Y, Xie B, Liu Z. 2013. The comparison of the efficacy of swine FMD vaccine emulsified with oil adjuvant of ISA 201 VG or ISA 206 VG. J. Biosci. Med. 1:22-25. http://dx.doi.org/10.4236/ jbm.2013.13005.
3. Rweyemamu M, Roeder P, Mackay D, Sumption K, Brownlie J, Leforban Y, Valarcher JF, Knowles NJ, Saraiva V. 2008. Epidemiological patterns of foot-and-mouth disease worldwide. Transbound. Emerg. Dis. 55:57-72. http://dx.doi.org/10.1111/j.1865-1682.2007.01013.x.
4. Ward MP, Laffan SW, Highfield LD. 2007. The potential role of wild and feral animals as reservoirs of foot-and-mouth disease. Prev. Vet. Med. 80:9-23. http://dx.doi.org/10.1016/j.prevetmed.2007.01.009. (Pubitemid 46441516)
5. Yamanaka M, Okabe T, Nakai M, Goto N. 1993. Local pathological reactions and immune response of chickens to ISA-70 and other adjuvants containing Newcastle disease virus antigen. Avian Dis. 37:459-466. http://dx.doi.org/10. 2307/1591673.
6. Stone HD. 1997. Newcastle disease oil emulsion vaccines prepared with animal, vegetable, and synthetic oils. Avian Dis. 41:591-597. http://dx.doi.org/10.2307/1592149. (Pubitemid 27426656)
7. Vajdy M. 2011. Immunomodulatory properties of vitamins, flavonoids and plant oils and their potential as vaccine adjuvants and delivery systems. Expert Opin. Biol. Ther. 11:1501-1513. http://dx.doi.org/10.1517/14712598.2011.623695.
8. Roy P, Venugopalan AT, Koteeswaran A. 1999. Efficacy of live adjuvanted mesogenic Newcastle disease vaccine in chickens. Vaccine 17:2674-2676. http://dx.doi.org/10.1016/S0264-410X(99)00024-9. (Pubitemid 29314464)
9. Song X, Bao S, Wu L, Hu S. 2009. Ginseng stem-leaf saponins (GSLS) and mineral oil act synergistically to enhance the immune responses to vaccination against foot-and-mouth disease in mice. Vaccine 27:51-55. http://dx.doi.org/10. 1016/j.vaccine.2008.10.030.
10. Li Y, Yan X, Hu S. 2012. Ginseng stem-leaf saponins and oil adjuvant synergistically promote the immune responses to Newcastle disease in chickens. J. Anim. Vet. Adv. 11:2423-2428. http://dx.doi.org/10.3923/javaa.2012.2423.2428.
11. Xu WP. 2008. Analysis and outlook of the current market of edible vegetable oil. Agric. Outlook 3:10-13.
12. China State Bureau of Standards. 2004. National standard of the People's Republic of China (GB 1536): rapeseed oil. China Standards Press, Beijing, China.
13. Chinese Veterinary Pharmacopoeia Commission. 2010. Total ginsenoside of ginseng stems and leaves, p 529-530. In Veterinary pharmacopoeia of People's Republic of China, part II. China Agricultural Press, Beijing, China.
14. Chinese Pharmacopoeia Commission. 2010. Total ginsenoside ginseng root, p 367-368. In Pharmacopoeia of People's Republic of China, part I. China Medical Science and Technology Press, Beijing, China.
15. Stone HD. 1993. Efficacy of experimental animal and vegetable oil-emulsion vaccines for Newcastle disease and avian influenza. Avian Dis. 37:399-405. http://dx.doi.org/10.2307/1591665.
16. Xie F, Li Y, Su F, Hu S. 2012. Adjuvant effect of Atractylodis macrocephalae Koidz. polysaccharides on the immune response to foot-and-mouth disease vaccine. Carbohydr. Polym. 87:1713-1719. http://dx.doi.org/10.1016/j. carbpol.2011.09.080.
17. Zhu J, Liu Y, Pi Y, Jia L, Wang L, Huang Y. 2014. Systemic application of sphingosine 1-phosphate receptor 1 immunomodulator inhibits corneal allograft rejection in mice. Acta Ophthalmol. 92:e12- e21. http://dx.doi.org/10.1111/aos. 12237.
18. Baldwin SL, Shaverdian N, Goto Y, Duthie MS, Raman VS, Evers T, Mompoint F, Vedvick TS, Bertholet S, Coler RN, Reed SG. 2009. Enhanced humoral and type 1 cellular immune responses with Fluzone adjuvanted with a synthetic TLR4 agonist formulated in an emulsion. Vaccine 27:5956-5963. http://dx.doi.org/10.1016/j. vaccine.2009.07.081.
19. Slifka MK, Matloubian M, Ahmed R. 1995. Bone marrow is a major site of long-term antibody production after acute viral infection. J. Virol. 69:1895-1902.
20. O'Connor BP, Cascalho M, Noelle RJ. 2002. Short-lived and long-lived bone marrow plasma cells are derived from a novel precursor population. J. Exp. Med. 195:737-745. http://dx.doi.org/10.1084/jem.20011626. (Pubitemid 34259718)
21. Rivera E, Hu S, Concha C. 2003. Ginseng and aluminium hydroxide act synergistically as vaccine adjuvants. Vaccine 21:1149-1157. http://dx.doi.org/ 10.1016/S0264-410X(02)00518-2. (Pubitemid 36142052)
22. Hu S, Concha C, Lin F, Persson WK. 2003. Adjuvant effect of ginseng extracts on the immune responses to immunisation against Staphylococcus aureus in dairy cattle. Vet. Immunol. Immunopathol. 91:29-37. http://dx.doi.org/10. 1016/S0165-2427(02)00264-7. (Pubitemid 36042796)
23. Meloen RH, Rowlands DJ, Brown F. 1979. Comparison of the antibodies elicited by the individual structural polypeptides of foot-and-mouth disease and polio viruses. J. Gen. Virol. 45:761-763. http://dx.doi.org/10.1099/0022-1317- 45-3-761. (Pubitemid 10184469)
24. McCullough KC, De Simone F, Brocchi E, Capucci L, Crowther JR, Kihm U. 1992. Protective immune response against foot-and-mouth disease. J. Virol. 66:1835-1840.
25. McCullough KC, Crowther JR, Butcher RN, Carpenter WC, Brocchi E, Capucci L, De Simone F. 1986. Immune protection against foot-and-mouth disease virus studied using virus-neutralizing and nonneutralizing concentrations of monoclonal antibodies. Immunology 58:421-428. (Pubitemid 16097641)
26. McCullough KC, Parkinson D, Crowther JR. 1988. Opsonization-enhanced phagocytosis of foot-and-mouth disease virus. Immunology 65:187-191.
27. Xie Q, Li Y, Zhang M. 2005. Detection of immune response to swine fever and FMD on a pig farm in Ningxia Province. Gansu J. Anim. Husb. Vet. 35:8-10.
28. Mayr GA, O'Donnell V, Chinsangaram J, Mason PW, Grubman MJ. 2001. Immune responses and protection against foot-and-mouth disease virus (FMDV) challenge in swine vaccinated with adenovirus-FMDV constructs. Vaccine 19:2152-2162. http://dx.doi.org/10.1016/S0264-410X(00)00384-4. (Pubitemid 32178366)
29. Xiao C, Rajput ZI, Hu S. 2007. Improvement of a commercial foot-and-mouth disease vaccine by supplement of Quil A. Vaccine 25:4795-4800. http://dx.doi.org/10.1016/j.vaccine.2007.04.027. (Pubitemid 46818618)
30. Male D, Roitt I, Brostoff J, Roteth D. 2012. Immunology, 8th ed. Saunders, Philadelphia, PA.
31. Tizard IR. 2009. Veterinary immunology: an introduction. Saunders, Philadelphia, PA.
32. Sun J, Hu S, Song X. 2007. Adjuvant effects of protopanaxadiol and protopanaxatriol saponins from ginseng roots on the immune responses to ovalbumin in mice. Vaccine 25:1114-1120. http://dx.doi.org/10.1016/j.vaccine. 2006.09.054. (Pubitemid 44937445)
33. Gerber JD. February 1989. Vaccine formation. US patent 4,806,350.
34. Martinez-Fernandez AR, Nogal-Ruiz JJ, Lopez-Aban J, Ramajo V, Oleaga A, Manga-Gonzalez Y, Hillyer GV, Muro A. 2004. Vaccination of mice and sheep with Fh12 FABP from Fasciola hepatica using the new adjuvant/immunomodulator system ADAD. Vet. Parasitol. 126:287-298. http://dx.doi.org/10.1016/j.vetpar.2004.07. 023. (Pubitemid 39572929)
35. Xiao C, Rajput ZI, Liu D, Hu S. 2007. Enhancement of serological immune responses to foot-and-mouth disease vaccine by a supplement made of extract of cochinchina momordica seeds. Clin. Vaccine Immunol. 14:1634-1639. http://dx.doi.org/10.1128/CVI.00339-07.
36. Manz RA, Radbruch A. 2002. Plasma cells for a lifetime? Eur. J. Immunol. 32:923-927. http://dx.doi.org/10.1002/1521-4141(200204)32:4<923::AID- IMMU923>3.0.CO;2-1.